Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 4 of 19 found articles
 
 
  Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial
 
 
Title: Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial
Author: Romera, Alvaro
Peredpaya, Sergiy
Shparyk, Yaroslav
Bondarenko, Igor
Mendonça Bariani, Giovanni
Abdalla, Kathia Cristina
Roca, Enrique
Franke, Fábio
Melo Cruz, Felipe
Ramesh, Anita
Ostwal, Vikas
Shah, Pradeep
Rahuman, Sajeed Abdul
Paravisini, Alexandra
Huerga, Camino
Del Campo García, Ana
Millán, Susana
Appeared in: The Lancet gastroenterology & hepatology
Paging: Volume 3 (2018) nr. 12 pages 845-855
Year: 2018
Contents:
Publisher: Elsevier Ltd
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 4 of 19 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands